Literature DB >> 28918387

Prospective comparative effectiveness cohort study comparing two models of advance care planning provision for Australian community aged care clients.

Karen Margaret Detering1,2, Rachel Zoe Carter1, Marcus William Sellars1,3, Virginia Lewis4, Elizabeth Anne Sutton1.   

Abstract

OBJECTIVES: Conduct a prospective comparative effectiveness cohort study comparing two models of advance care planning (ACP) provision in community aged care: ACP conducted by the client's case manager (CM) ('Facilitator') and ACP conducted by an external ACP service ('Referral') over a 6-month period.
METHODS: This Australian study involved CMs and their clients. Eligible CM were English speaking, ≥18 years, had expected availability for the trial and worked ≥3 days per week. CMs were recruited via their organisations, sequentially allocated to a group and received education based on the group allocation. They were expected to initiate ACP with all clients and to facilitate ACP or refer for ACP. Outcomes were quantity of new ACP conversations and quantity and quality of new advance care directives (ACDs).
RESULTS: 30 CMs (16 Facilitator, 14 Referral) completed the study; all 784 client's files (427 Facilitator, 357 Referral) were audited. ACP was initiated with 508 (65%) clients (293 Facilitator, 215 Referral; p<0.05); 89 (18%) of these (53 Facilitator, 36 Referral) and 41 (46%) (13 Facilitator, 28 Referral; p<0.005) completed ACDs. Most ACDs (71%) were of poor quality/not valid. A further 167 clients (facilitator 124; referral 43; p<0.005) reported ACP was in progress at study completion.
CONCLUSIONS: While there were some differences, overall, models achieved similar outcomes. ACP was initiated with 65% of clients. However, fewer clients completed ACP, there was low numbers of ACDs and document quality was generally poor. The findings raise questions for future implementation and research into community ACP provision. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  advance care directive; advance care planning; community aged care; home care packages

Mesh:

Year:  2017        PMID: 28918387     DOI: 10.1136/bmjspcare-2017-001372

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  5 in total

1.  The patient's relationship with the General Practitioner before and after Advance Care Planning: pre/post-implementation study.

Authors:  Annicka G M van der Plas; Julia E A P Schellekens; Jolien J Glaudemans; Bregje D Onwuteaka-Philipsen
Journal:  BMC Geriatr       Date:  2022-07-05       Impact factor: 4.070

2.  Whose job? The staffing of advance care planning support in twelve international healthcare organizations: a qualitative interview study.

Authors:  Josie Dixon; Martin Knapp
Journal:  BMC Palliat Care       Date:  2018-05-24       Impact factor: 3.234

3.  Prolonged Wait Time Prior to Entry to Home Care Packages Increases the Risk of Mortality and Transition to Permanent Residential Aged Care Services: Findings from the Registry of Older South Australians (ROSA).

Authors:  R Visvanathan; A T Amare; S Wesselingh; R Hearn; S McKechnie; J Mussared; M C Inacio
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

4.  Protocol for a national prevalence study of advance care planning documentation and self-reported uptake in Australia.

Authors:  Rasa Ruseckaite; Karen M Detering; Sue M Evans; Veronica Perera; Lynne Walker; Craig Sinclair; Josephine M Clayton; Linda Nolte
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

5.  A cost-consequence analysis of normalised advance care planning practices among people with chronic diseases in hospital and community settings.

Authors:  Sarah Jeong; Se Ok Ohr; Peter Cleasby; Tomiko Barrett; Ryan Davey; Simon Deeming
Journal:  BMC Health Serv Res       Date:  2021-07-23       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.